AURA
Price:
$10.04
Market Cap:
$498.05M
Aura Biosciences, Inc. operates as a biotechnology company that develops therapies to treat cancer. The company develops virus-like drug conjugates (VDC) technology platform for the treat tumors of high unmet need in ocular and urologic oncology. It develops AU-011, a VDC candidate for the treatment of primary choroidal melanoma. It also develops AU-011 in additional ocular oncology indications, including choroidal metastases. The company was incorporated in 2009 and is headquartered in Cambridge, Massachusetts.[Read more]
Industry
Biotechnology
IPO Date
2021-10-29
Stock Exchange
NASDAQ
Ticker
AURA
According to Aura Biosciences, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 487.00M. This represents a change of 38.14% compared to the average of 352.56M of the last 4 quarters.
The mean historical Enterprise Value of Aura Biosciences, Inc. over the last ten years is 341.23M. The current 487.00M Enterprise Value has changed 14.17% with respect to the historical average. Over the past ten years (40 quarters), AURA's Enterprise Value was at its highest in in the March 2022 quarter at 535.15M. The Enterprise Value was at its lowest in in the March 2020 quarter at 0.
Average
341.23M
Median
347.93M
Minimum
213.62M
Maximum
415.07M
Discovering the peaks and valleys of Aura Biosciences, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 54.25%
Maximum Annual Enterprise Value = 415.07M
Minimum Annual Increase = -38.60%
Minimum Annual Enterprise Value = 213.62M
Year | Enterprise Value | Change |
---|---|---|
2023 | 329.51M | 54.25% |
2022 | 213.62M | -38.60% |
2021 | 347.93M | -16.18% |
2020 | 415.07M | 3.76% |
The current Enterprise Value of Aura Biosciences, Inc. (AURA) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
297.02M
5-year avg
341.23M
10-year avg
341.23M
Aura Biosciences, Inc.’s Enterprise Value is greater than Aerovate Therapeutics, Inc. (47.55M), greater than Adagene Inc. (59.89M), greater than Acrivon Therapeutics, Inc. Common Stock (202.59M), greater than Rezolute, Inc. (242.23M), greater than AN2 Therapeutics, Inc. (5.46M), greater than Seer, Inc. (119.85M), less than ORIC Pharmaceuticals, Inc. (627.68M), greater than Anebulo Pharmaceuticals, Inc. (45.92M), less than Cullinan Oncology, Inc. (800.26M), greater than C4 Therapeutics, Inc. (440.16M), less than Crinetics Pharmaceuticals, Inc. (4.78B), greater than ALX Oncology Holdings Inc. (78.84M), less than Immatics N.V. (884.39M), greater than BioAtla, Inc. (35.22M), less than Opthea Limited (658.08M),
Company | Enterprise Value | Market cap |
---|---|---|
47.55M | $77.94M | |
59.89M | $135.03M | |
202.59M | $244.37M | |
242.23M | $310.40M | |
5.46M | $32.23M | |
119.85M | $124.70M | |
627.68M | $674.74M | |
45.92M | $49.01M | |
800.26M | $912.55M | |
440.16M | $432.71M | |
4.78B | $5.03B | |
78.84M | $76.90M | |
884.39M | $1.10B | |
35.22M | $95.22M | |
658.08M | $629.92M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Aura Biosciences, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Aura Biosciences, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Enterprise Value?
How can you use the Enterprise Value?
What is Aura Biosciences, Inc.'s Enterprise Value?
What is the highest Enterprise Value for Aura Biosciences, Inc. (AURA)?
What is the 3-year average Enterprise Value for Aura Biosciences, Inc. (AURA)?
What is the 5-year average Enterprise Value for Aura Biosciences, Inc. (AURA)?
How does the current Enterprise Value for Aura Biosciences, Inc. (AURA) compare to its historical average?